Skip to content

Drug Delivery

Frontiers in Drug Delivery ·

Volume 4 - 2024 | https://doi.org/10.3389/fddev.2024.1519969

Corrigendum: Preliminary results on novel adjuvant combinations suggest enhancement immunogenicity of whole inactivated pandemic influenza vaccines

  • Allegra Peletta1*corresponding author
  • Aurélie Marmy1
  • Samo Guzelj2
  • Alcidia Ramos Barros1
  • Žiga Jakopin2
  • Gerrit Borchard1
  1. 11 Section of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Geneva, Switzerland
  2. 22 Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Article metrics0 viewsView details

Abstract

Keywords

In the published article, there was an error in the Funding statement. “Swiss National founding, grant no: 20 IZCOZ0_182947” was included incorrectly. Instead, it should appear as “Swiss National Science Foundation (SNF), grant no: IZCOZ0_182947.” The correct Funding statement appears below.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Swiss National Science Foundation (SNF), grant no: IZCOZ0_182947.

In the published article, there was an error. The following sentence was mistakenly not included in the Acknowledgments: “The research was funded by Swiss National Science Foundation (SNF), grant no: IZCOZ0_182947.”

The correct Acknowledgments appears below:

“The authors would like to warmly thank the Vaccine Formulation Institute, particularly Dr. Nicolas Collin, Dr. Stéphanie Romand, Dr. Céline Lemoine, Dr. Livia Brunner, and Florian Gobet for their huge contribution to the project. They specifically thank Dr. Romand for the development of the LC-MS protocol, M. Gobet for his help with animal studies, and Dr. Lemoine and Dr. Brunner for their help in building the project as well as advice on multiple occasions. The research was funded by Swiss National Science Foundation (SNF), grant no: IZCOZ0_182947.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Citation

Peletta, A., et al. (2024). Corrigendum: Preliminary results on novel adjuvant combinations suggest enhancement immunogenicity of whole inactivated pandemic influenza vaccines. Frontiers in Drug Delivery, Volume 4. https://doi.org/
Received
Accepted
Published
Volume
4 - 2024

Copyright

Copyright © 2024 Peletta, Marmy, Guzelj, Ramos Barros, Jakopin and Borchard.

License: http://creativecommons.org/licenses/by/4.0/

*Correspondence: Allegra Peletta

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0